Today's news was filled with scares about the new coronavirus traced from the Chinese city of Wuhan and potentially spreading worldwide, For those of us who experienced the SARS outbreak in 2002-2003, that is alarming. Yet, At the same time, some other encouraging information is being explored.
A relatively unknown Cannabis cannabinoid, Cannabigerol (affectionately known as CBG) has heralded some exciting news. A new study may prove it is effective fighting against antibiotic resistant bugs. Five Cannabis compounds were investigated for their antibiotic properties and CBG was found particularly effective in killing methicillin-resistant Staphylococcus aureus (MRSA), a superbug that hospitals are battling. This finding was reported in an unrefereed preprint study from McMaster University, a study that is still awaiting to be peer reviewed before it can be officially published.(https://www.biorxiv.org/content/10.1101/833392v3.full).
Cannabinoids are chemicals that give Cannabis its medical and recreational properties
CBGA (Cannabigerolic acid before it is heated and loses its acid) is the precursor to three main cannabinoid lines: THCA, CBDA and CBCA. Within the growing period, enzymes in the Cannabis plant break CBGA down and direct it primarily toward THCA and CBDA strains.
That is why there are typically low levels of CBG in Cannabis strains. Breeders now are experimenting to produce higher levels of CBG from budding plants by finding the optimum time, about six weeks into an eight week flowering cycle, to extract higher levels of CBG.
CBG is not psychoactive and has long been recognized as having antibacterial and anti-inflammatory properties. Other studies suggest this cannabinoid stimulates growth of new brain cells, bone growth, and also combats insomnia.